BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16128221)

  • 1. Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis.
    Cirillo I; Vizzaccaro A; Tosca MA; Negrini S; Negrini AC; Marseglia G; Ciprandi G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):79-83. PubMed ID: 16128221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis.
    Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
    Respir Med; 2004 Sep; 98(9):826-31. PubMed ID: 15338793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis.
    Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
    Int Arch Allergy Immunol; 2004 Jan; 133(1):14-8. PubMed ID: 14646374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
    Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
    Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.
    Marseglia GL; Cirillo I; Vizzaccaro A; Klersy C; Tosca MA; La Rosa M; Marseglia A; Licari A; Leone M; Ciprandi G
    Allergy Asthma Proc; 2007; 28(1):74-8. PubMed ID: 17390762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis.
    Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
    Clin Mol Allergy; 2004 Mar; 2(1):3. PubMed ID: 15018619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis.
    Ciprandi G; Tosca MA; Castellazzi AM; Cairello F; Salpietro C; Arrigo T; Miraglia Del Giudice M
    Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):17-20. PubMed ID: 22032781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal and perennial allergic rhinitis: is this classification adherent to real life?
    Ciprandi G; Cirillo I; Vizzaccaro A; Tosca M; Passalacqua G; Pallestrini E; Canonica GW
    Allergy; 2005 Jul; 60(7):882-7. PubMed ID: 15932377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary function parameters in patients with allergic rhinitis.
    Bavbek S; Saryal S; Karabiyikoglu G; Misirligil Z
    J Investig Allergol Clin Immunol; 2003; 13(4):252-8. PubMed ID: 14989114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness.
    Henriksen AH; Sue-Chu M; Holmen TL; Langhammer A; Bjermer L
    Eur Respir J; 1999 Feb; 13(2):301-6. PubMed ID: 10065672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis.
    Prieto JL; Gutiérrez V; Bertó JM; Camps B
    Clin Exp Allergy; 1996 Jan; 26(1):61-7. PubMed ID: 8789544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
    Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
    Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor.
    Ciprandi G; Tosca MA; Signori A; Cirillo I
    Allergy Asthma Proc; 2011; 32(2):4-8. PubMed ID: 21439158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis.
    Mete N; Sin A; Gulbahar O; Erdinc M; Sebik F; Kokuludag A
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):193-9. PubMed ID: 15328682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patients.
    Cirillo I; Klersy C; Marseglia GL; Vizzaccaro A; Pallestrini E; Tosca M; Ciprandi G
    Ann Allergy Asthma Immunol; 2006 May; 96(5):692-700. PubMed ID: 16729782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening spirometry to detect respiratory allergy.
    Cirillo I; Klersy C; Marseglia G; Tosca M; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):146-8. PubMed ID: 17058845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective and objective assessments of seasonal effect in children with seasonal allergic rhinitis.
    Ginis T; Bostanci I; Ozmen S; Misirlioglu ED; Dogru M; Duman H
    Int J Pediatr Otorhinolaryngol; 2015 Mar; 79(3):405-10. PubMed ID: 25604260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.
    Cirillo I; Medusei G; Signori A; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):123-9. PubMed ID: 24067337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal airflow recovery after decongestion test is associated with bronchial hyperreactivity in patients with allergic rhinitis.
    Ciprandi G; Cirillo I; Klersy C; Vizzaccaro A; Tosca MA; Marseglia GL
    Otolaryngol Head Neck Surg; 2006 Feb; 134(2):255-9. PubMed ID: 16455374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower airways may also be affected in asymptomatic patients with recent onset of allergic rhinitis.
    Ciprandi G; Cirillo I; Klersy C
    Laryngoscope; 2010 Jul; 120(7):1288-91. PubMed ID: 20578230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.